tradingkey.logo

Sharps Technology Inc

STSS
1.650USD
+0.225+15.79%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
45.58MValor de mercado
PerdaP/L TTM

Sharps Technology Inc

1.650
+0.225+15.79%

Mais detalhes de Sharps Technology Inc Empresa

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.

Informações de Sharps Technology Inc

Código da empresaSTSS
Nome da EmpresaSharps Technology Inc
Data de listagemApr 14, 2022
CEOMr. Robert M. Hayes
Número de funcionários5
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 14
Endereço105 Maxess Road
CidadeMELVILLE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal11747
Telefone15162464000
Sitehttps://sharpstechnology.com/
Código da empresaSTSS
Data de listagemApr 14, 2022
CEOMr. Robert M. Hayes

Executivos da empresa Sharps Technology Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Yuwen (Alice) Zhang
Ms. Yuwen (Alice) Zhang
Chief Investment Officer, Director
Chief Investment Officer, Director
14.04K
+14040.00%
Mr. Andrew R. Crescenzo, CPA
Mr. Andrew R. Crescenzo, CPA
Chief Financial Officer
Chief Financial Officer
2.00
--
Mr. Paul K. Danner
Mr. Paul K. Danner
Executive Chairman of the Board, Principal Executive Officer
Executive Chairman of the Board, Principal Executive Officer
--
--
Mr. Timothy J. Ruemler
Mr. Timothy J. Ruemler
Independent Director
Independent Director
--
--
Mr. Jason L. Monroe
Mr. Jason L. Monroe
Independent Director
Independent Director
--
--
Mr. Adam Holdsworth
Mr. Adam Holdsworth
Investor Relations
Investor Relations
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Yuwen (Alice) Zhang
Ms. Yuwen (Alice) Zhang
Chief Investment Officer, Director
Chief Investment Officer, Director
14.04K
+14040.00%
Mr. Andrew R. Crescenzo, CPA
Mr. Andrew R. Crescenzo, CPA
Chief Financial Officer
Chief Financial Officer
2.00
--
Mr. Paul K. Danner
Mr. Paul K. Danner
Executive Chairman of the Board, Principal Executive Officer
Executive Chairman of the Board, Principal Executive Officer
--
--
Mr. Timothy J. Ruemler
Mr. Timothy J. Ruemler
Independent Director
Independent Director
--
--
Mr. Jason L. Monroe
Mr. Jason L. Monroe
Independent Director
Independent Director
--
--
Mr. Adam Holdsworth
Mr. Adam Holdsworth
Investor Relations
Investor Relations
--
--

Detalhamento da receita

Os dados relevantes ainda não foram divulgados pela empresa.
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: dom, 1 de fev
Atualizado em: dom, 1 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Saba Capital Management, L.P.
10.52%
Schonfeld Strategic Advisors LLC
5.31%
Bastion Trading Ltd
4.93%
Pantera Capital Partners LP
3.97%
The Vanguard Group, Inc.
1.80%
Outro
73.48%
Investidores
Investidores
Proporção
Saba Capital Management, L.P.
10.52%
Schonfeld Strategic Advisors LLC
5.31%
Bastion Trading Ltd
4.93%
Pantera Capital Partners LP
3.97%
The Vanguard Group, Inc.
1.80%
Outro
73.48%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
10.56%
Investment Advisor
6.50%
Hedge Fund
5.31%
Corporation
4.93%
Pension Fund
0.28%
Individual Investor
0.12%
Research Firm
0.08%
Venture Capital
0.04%
Outro
72.18%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
42
5.29M
18.26%
+3.62M
2025Q3
32
24.05K
0.09%
-49.29K
2025Q2
33
49.45K
5.94%
+26.45K
2025Q1
39
63.33K
6.22%
+60.72K
2024Q4
33
355.71K
5.82%
+134.96K
2024Q3
33
124.60K
7.17%
-86.28K
2024Q2
32
148.09K
20.99%
+9.96K
2024Q1
27
169.97K
24.07%
+27.63K
2023Q4
28
254.51K
44.37%
+113.61K
2023Q3
28
231.44K
42.60%
+113.95K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Schonfeld Strategic Advisors LLC
1.54M
5.45%
+1.54M
--
Sep 30, 2025
Pantera Capital Partners LP
1.15M
4.07%
+1.15M
--
Sep 30, 2025
The Vanguard Group, Inc.
17.85K
0.06%
+5.59K
+45.56%
Sep 30, 2025
Voya Investments, LLC
183.34K
0.65%
+183.34K
--
Oct 31, 2025
OMERS Administration Corporation
81.33K
0.29%
+81.33K
--
Sep 30, 2025
Ruemler (Timothy James)
20.22K
0.07%
+57.00
+0.28%
Sep 09, 2025
Zhang (Yuwen)
14.04K
0.05%
+14.04K
--
Sep 09, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Apr 24, 2025
Merger
300→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Data
Data ex-dividendo
Tipo
Proporção
Apr 24, 2025
Merger
300→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
KeyAI